RT Journal Article
SR Electronic
T1 Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4+ and CD8+ T-cell clusters in Systemic Sclerosis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.23.20190462
DO 10.1101/2020.09.23.20190462
A1 N.H. Servaas
A1 F. Zaaraoui-Boutahar
A1 C.G.K. Wichers
A1 A. Ottria
A1 E. Chouri
A1 A.J. Affandi
A1 S. Silva-Cardoso
A1 M. van der Kroef
A1 T. Carvalheiro
A1 F. van Wijk
A1 T.R.D.J. Radstake
A1 A.C. Andeweg
A1 A. Pandit
YR 2020
UL http://medrxiv.org/content/early/2020/09/23/2020.09.23.20190462.abstract
AB The T-cell receptor (TCR) is a highly polymorphic surface receptor that allows T-cells to recognize antigenic peptides presented on the major histocompatibility complex (MHC). Changes in the TCR repertoire have been observed in several autoimmune conditions, and these changes are suggested to predispose autoimmunity. Multiple lines of evidence have implied an important role for T-cells in the pathogenesis of Systemic Sclerosis (SSc), a complex autoimmune disease. One of the major questions regarding the roles of T-cells is whether expansion and activation of T-cells observed in the diseases pathogenesis is (auto)antigen driven.To investigate the temporal TCR repertoire dynamics in SSc, we performed high-throughput sequencing of CD4+ and CD8+ TCRβ chains on longitudinal samples obtained from four SSc patients collected over a minimum of two years. Repertoire overlap analysis revealed that samples taken from the same individual over time shared a high number of TCRβ sequences, indicating a clear temporal persistence of the TCRβ repertoire in CD4+ as well as CD8+ T-cells. Moreover, the TCRβs that were found with a high frequency at one time point were also found with a high frequency at the other time points (even after almost four years), showing that frequencies of dominant TCRβs are largely consistent over time. We also show that TCRβ generation probability and observed TCR frequency are not related in SSc samples, showing that clonal expansion and persistence of TCRβs is caused by antigenic selection rather than convergent recombination. Moreover, we demonstrate that TCRβ diversity is lower in CD4+ and CD8+ T-cells from SSc patients compared to healthy memory T-cells, as SSc TCRβ repertoires are largely dominated by clonally expanded persistent TCRβ sequences. Lastly, using “Grouping of Lymphocyte Interactions by Paratope Hotspots” (GLIPH2), we identify clusters of TCRβ sequences with homologous sequences that potentially recognize the same antigens and contain TCRβs that are persist in SSc patients.In conclusion, our results show that that CD4+ and CD8+ T-cells are highly persistent in SSc patients over time, and this persistence is likely a result from antigenic selection. Moreover, persistent TCRs form high similarity clusters with other (non-)persistent sequences, that potentially recognize the same epitopes. These data provide evidence for an (auto-)antigen driven expansion of CD4/CD8+ T-cells in SSc.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was supported by the Center of Translational Immunology at the UMC Utrecht, which is a non-profit research organization. A.P. was supported by Netherlands Organization for Scientific Research (NWO) grant number: 016.Veni.178.027. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted in accordance with the Declaration of Helsinki and was performed with approval of the Institutional Review Board of the University Medical Centre (UMC) Utrecht, The Netherlands. The medical ethics committee of the UMC Utrecht approved the study (METC nr 13-697). All participants enrolled in the study signed informed, and patient samples were anonymized upon collection.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe TCRβ sequencing data presented in this study have been deposited in NCBI's Gene Expression Omnibus (GEO) database under GEO: GSE156980. Both raw data and processed data are available. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE156980